Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 8 Sept, 08:00 pm
Strong Financial Performance: Snowflake's Q2 FY27 saw product revenues jump 37% to $1.49 billion and total revenues grow 35.1% to $1.55 billion , exceeding analyst expectations. AI as a Growth Catalyst: Artificial intelligence (AI) is a major driver, contributing to half of Snowf
Planet Labs PBC exceeded Q2 2026 financial expectations, reporting a positive earnings per share of $0.02 against an anticipated loss. The Earth-imaging satellite company posted strong revenue of $116.05 million , significantly beating analyst forecasts and marking a 58% year-ove
Shell plc (NYSE: SHEL) completed its acquisition of ARC Resources Ltd. (TSX: ARX) , substantially expanding its operations in Canada’s Montney basin. Shell agreed to acquire the remaining 67% stake in Tri Star Energy , which would give it full ownership of 320 retail sites
BetterHelp President Fernando M. Rodrigues sold 9,812 shares of Teladoc Health common stock for $6.51 per share, totaling $63,876.00 . The BetterHelp segment experienced significant challenges, with revenues declining by 11.6% and adjusted EBITDA margin falling to 0.2% in Q2 2026
Zscaler (NASDAQ: ZS) reported impressive fiscal Q4 results, surpassing analyst expectations for both earnings and revenue. Strategic investments in Artificial Intelligence (AI) and a workforce restructuring are key drivers behind the company's robust revenue growth . Zscaler (NAS
Top Stock Market Losers: Ultragenyx Trial Failure, Polestar Outlook Cut, and Inverse ETFs Lead Declines Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) plunged after its experimental Angelman syndrome treatment failed a Phase 3 trial. Polestar Automotive Holding UK PLC (NASDAQ: PSN
Top Stock Gainers: ChargePoint Holdings (NYSE: CHPT) Leads Market Surge ChargePoint Holdings, Inc. (NYSE: CHPT) surged nearly 74% after reporting stronger fiscal second-quarter results, including higher revenue and a substantially narrower loss. Antelope Enterprise Holdings Limit
Ciena (NYSE: CIEN) Falls Despite Strong Q3 Results and AI-Driven Demand Strong Financial Results: Ciena Corporation (NYSE: CIEN) reported fiscal third-quarter 2026 adjusted EPS of $2.11 , up 215% year over year and above analysts’ expectations. AI and Cloud Demand: Revenue
Kazia Therapeutics is set to release earnings with estimated EPS of -$0.61 and revenues of $0.49 million , reflecting its development stage. The company's main drug candidate, paxalisib, shows promise in preclinical colorectal cancer models and is advancing to a Phase 2 study, wi
Analyst Upgrade: Hutchison China MediTech Limited (NASDAQ:HCM) received a "Buy" rating upgrade from Daiwa, with a new price target of $18.50 . Strategic GSK Partnership: This positive outlook is largely due to a significant co-development and licensing agreement with GSK (NYSE: G
BRP Inc. (NASDAQ: DOO) Raises Fiscal 2027 Outlook Despite Quarterly Loss BRP Inc. (NASDAQ: DOO) reported C$2.24 billion in revenue , an 18.5% year-over-year increase driven by higher off-road vehicle shipments. The company recorded a C$136.8 million net loss , compared with C$57.
Duluth Holdings Inc. (NASDAQ:DLTH) reported a significant Q2 EPS beat of $0.50 , far exceeding the -$0.01 consensus estimate, largely due to $0.44 per share from tariff refunds. While quarterly revenue of $121.39 million surpassed analyst estimates, it marked a decline from the p
Leadership Transition: The Estée Lauder Companies (NYSE: EL) recently announced significant brand leadership appointments, signaling strategic shifts within its competitive beauty market presence. Insider Activity: A notable insider transaction occurred with an executive selling
HUTCHMED (NASDAQ: HCM) shares experienced a significant surge following the announcement of a major co-development and licensing agreement with pharmaceutical giant GSK. The deal centers on HUTCHMED's preclinical cancer therapy, HMPL-A830, granting GSK exclusive rights outside Gr
Genesco (NYSE:GCO) reported better-than-expected second-quarter earnings , significantly surpassing analyst estimates despite a challenging retail environment . Improved profitability was driven by a higher adjusted gross margin and effective expense management , narrowing the ad
Samsara is set to release its quarterly earnings on September 3rd, 2026, with analysts forecasting an EPS of $0.16 and revenue of $483.29 million . The company has a strong track record, beating earnings estimates in the last four quarters with an average surprise of 41.4% . Inve
Brady Corporation (NYSE: BRC) exceeded analyst expectations with its fourth-quarter earnings, reporting an adjusted EPS of $1.48 . The company achieved significant revenue growth of $436.9 million , driven by strong organic sales and strategic acquisitions. Brady Corporation main
Telsey Advisory adjusted its outlook on G-III Apparel Group (NASDAQ: GIII) , lowering its price target to $32.00 from $38.00 , suggesting a potential 15.57% upside from its trading price of $27.69 . Despite a decrease in net sales to $554.10 million from $613.30 million , the com
Headlines provided by Investing.com